Literature DB >> 12620791

Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4.

Nikola Kaludov1, Eric Padron, Lakshmanan Govindasamy, Robert McKenna, John A Chiorini, Mavis Agbandje-McKenna.   

Abstract

Adeno-associated virus (AAV) serotypes 1 to 5 are currently under development as clinical gene delivery vectors for the treatment of human diseases. However, the ubiquitous nature of their cell surface receptors, heparin sulfate (AAV2 and 3) and sialic acids (AAV4 and 5), can preclude specific tissue targeting in vivo. Structural studies of AAV4 were initiated to characterize its capsid surface for re-targeting manipulations. Crystals obtained diffracted synchrotron radiation to 3.2 A resolution. The unit cell is body-centered orthorhombic, I222, with a = 339.6, b = 319.2 and c = 285.0 A. The virus particle orientation and position have been determined.

Entities:  

Mesh:

Year:  2003        PMID: 12620791     DOI: 10.1016/s0042-6822(02)00037-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.

Authors:  Lakshmanan Govindasamy; Eric Padron; Robert McKenna; Nicholas Muzyczka; Nikola Kaludov; John A Chiorini; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7.

Authors:  Odayme Quesada; Brittney Gurda; Lakshmanan Govindasamy; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Sergei Zolotukhin; Nicholas Muzyczka; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-30

4.  Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies.

Authors:  Thomas F Lerch; Qing Xie; Heather M Ongley; Joan Hare; Michael S Chapman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

5.  Crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 6.

Authors:  Qing Xie; Heather M Ongley; Joan Hare; Michael S Chapman
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

6.  Structure of adeno-associated virus type 4.

Authors:  Eric Padron; Valorie Bowman; Nikola Kaludov; Lakshmanan Govindasamy; Hazel Levy; Phillip Nick; Robert McKenna; Nicholas Muzyczka; John A Chiorini; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 7.  AAV hybrid serotypes: improved vectors for gene delivery.

Authors:  Vivian W Choi; Douglas M McCarty; R Jude Samulski
Journal:  Curr Gene Ther       Date:  2005-06       Impact factor: 4.391

8.  Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain.

Authors:  Nikisha Carty; Daniel Lee; Chad Dickey; Carolina Ceballos-Diaz; Karen Jansen-West; Todd E Golde; Marcia N Gordon; Dave Morgan; Kevin Nash
Journal:  J Neurosci Methods       Date:  2010-10-15       Impact factor: 2.390

9.  Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5.

Authors:  Michael DiMattia; Lakshmanan Govindasamy; Hazel C Levy; Brittney Gurda-Whitaker; Amy Kalina; Erik Kohlbrenner; John A Chiorini; Robert McKenna; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-30

Review 10.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.